TESTOSTERONE CYPIONATE INJECTION USP DIN 02570122
Health Canada record
| Active ingredient(s) | TESTOSTERONE CYPIONATE 100 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular |
| Schedule | CONTROLLED DRUGS (CDSA IV) |
| Class | Human |
| ATC | G03BA03 TESTOSTERONE |
| Original market date | |
| Current status date | 20-Jul-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sterimax Inc — licence 100925, currently licensed, last inspection rating C (2024-05-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TESTOSTERONE CYPIONATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02496003 | TARO-TESTOSTERONE CYPIONATE INJECTION | TARO PHARMACEUTICALS INC | Solution | TESTOSTERONE CYPIONATE 100 MG | Marketed |
| 00030783 | DEPO-TESTOSTERONE INJ 100MG/ML | PFIZER CANADA ULC | Solution | TESTOSTERONE CYPIONATE 100 MG | Cancelled Post Market |
| 02220318 | SCHEINPHARM TESTONE-CYP INJECT.- IM 100MG/ML | SCHEIN PHARMACEUTICAL CANADA INC. | Liquid | TESTOSTERONE CYPIONATE 100 MG | Cancelled Post Market |
| 02246063 | TESTOSTERONE CYPIONATE INJECTION USP | SANDOZ CANADA INCORPORATED | Liquid | TESTOSTERONE CYPIONATE 100 MG | Cancelled Post Market |
| 01977601 | TESTOSTERONE CYPIONATE INJECTION, USP | STERIMAX INC | Liquid | TESTOSTERONE CYPIONATE 100 MG | Cancelled Post Market |
International API supply for TESTOSTERONE CYPIONATE
9 active FDA Drug Master Files.
Request a quote for TESTOSTERONE CYPIONATE INJECTION USP